Spain· ES:61831
GEMFIBROZILO STADA 900 mg COMPRIMIDOS EFG
A medicinal product containing gemfibrozilo, registered in Spain by Laboratorio Stada S.L..
Checked against AEMPS CIMA (Spain) on
Informational only — not a medical device.
The record
At a glance
AEMPS CIMA (Spain)- Active substance
- gemfibrozilo
- Manufacturer
- Laboratorio Stada S.L.
- Country
- Spain (ES)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- AEMPS CIMA (Spain)
- Last checked
- August 12, 2026
Packs & prices · 1
1 priced- cima_codigo66476330EUR 7.35
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Gemfibrozilo in 11 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- ItalyGEMFIBROZIL DOC GENERICIDOC GENERICI S.R.L.
- United StatesGemfibrozilNuCare Pharmaceuticals,Inc.
- United KingdomGemfibrozil 300mg capsulesTeva UK Ltd
- FinlandGevilonOrion Corporation Orion Pharma
- NetherlandsGemfibrozil Auro 600 mg, filmomhulde tablettenAurobindo Pharma B.V.
- IrelandLopid 300 mg capsules, hardPfizer Healthcare Ireland Unlimited Company
- NorwayLopidPfizer
- CanadaTEVA-GEMFIBROZILTEVA CANADA LIMITED
Authorised across Europe · EMA
The same active substance is authorised in 11 EEA countries. Names it is sold under:
- Austria · Gevilon
- Cyprus · Ipolipid, Lipofor
- Denmark · Lopid
- France · Lipur
- United Kingdom (Northern Ireland) · Gemfibrozil Tillomed Laboratories, Lopid
- Greece · Fibrolip, Gemlipid
- Ireland · Lopid
- Iceland · Lopid
- Italy · Gemfibrozil Doc Generici, Gemfibrozil Eg
- Netherlands · Gemfibrozil Aurobindo, Lopid
- Portugal · Gemfibrozil Generis, Lopid
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of AEMPS CIMA (Spain). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/edb72667-b4f5-45c8-be30-a27a70705408 GET /v1/drugs/edb72667-b4f5-45c8-be30-a27a70705408?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cpresc": "Medicamento Sujeto A Prescripción Médica. Tratamiento De Larga Duración",
"estado": "{\"aut\":880930800000}",
"nregistro": "61831",
"substance": "gemfibrozilo"
}See everything about gemfibrozilo.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.